Covered recipient · General Payments record
VEENA N VANGANI
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$9,527.39
- Reported across 578 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,595.71 | 90 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $427.67 | 24 |
| Novo Nordisk AS | $162.28 | 8 |
| PFIZER INC. | $152.14 | 10 |
| Amgen Inc. | $144.63 | 9 |
| Lilly USA, LLC | $81.26 | 4 |
| Bayer HealthCare Pharmaceuticals Inc. | $78.85 | 5 |
| Exact Sciences Corporation | $47.82 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $36.26 | 2 |
| E.R. Squibb & Sons, L.L.C. | $35.85 | 2 |
| Actelion Pharmaceuticals US, Inc. | $34.42 | 2 |
| GlaxoSmithKline, LLC. | $33.41 | 2 |
| Acerta Pharma LLC | $30.10 | 2 |
| Ardelyx, Inc. | $28.99 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $25.24 | 1 |
| Axsome Therapeutics, Inc. | $24.23 | 1 |
| Abbott Laboratories | $23.54 | 1 |
| DEXCOM, INC. | $23.31 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.91 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $20.00 | 1 |
| EISAI INC. | $19.25 | 1 |
| Edwards Lifesciences Corporation | $19.20 | 1 |
| Merck Sharp & Dohme Corporation | $18.95 | 1 |
| Otsuka America Pharmaceutical, Inc. | $18.86 | 1 |
| Averitas Pharma Inc. | $16.74 | 1 |
| Biogen, Inc. | $14.90 | 1 |
| Phathom Pharmaceuticals, Inc. | $14.38 | 1 |
| Neurelis, Inc. | $14.08 | 1 |
| Medtronic, Inc. | $13.87 | 1 |
| WATERMARK MEDICAL, INC. | $13.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (90)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.